Dr Leonid Shapiro chairs UAE-UK Business Council panel on AI in Drug development in Dubai
30 January 2025Arab Health Exhibition 2025: 50 Years of Advancing Global Healthcare!From just 40 exhibitors to a powerhouse event with 180+ countries…Ethics Symposium – AI in Medicines
12 December 2024In December, the Royal Society of Medicine was host to the Ethos Pharmaceutical Ethics & Compliance Charity Symposium, and this…Doctorpreneurs non-code Hackathon
2 December 2024đ©șOn Saturday 30th November, Candesic Analyst Dr Matthew Yeoh attended the Huma Cloud and Doctorpreneurs hackathon held at their HQ…Schroders Future of AI talk
25 November 2024Rounding off a great week and month of November, Candesic Managing Partner Dr Leonid Shapiro took the stage at a…The use of GenAI in clinical practice
25 September 2024A BMJ survey of 1,000 GPs found that twenty per cent of GPs have used GenAI in clinical practice, but…Not-to-be-missed webinar takes place next week
18 April 2024A reminder that a not-to-be-missed webinar takes place next week! Candesic Senior Partner Dr Michelle Tempest will be kicking off the Royal Society of…Rise of the organoids
28 February 2024Candesic Managing Partner Dr Leonid Shapiro and Principal Dr Joe Taylor explore the intriguing applications of cerebral organoids in the latest edition of PharmaTimes. These artificially…What does the EU framework for AI innovation and regulation mean for the future of healthcare in Europe?
18 December 2023What does the EU framework for AI innovation and regulation mean for the future of healthcare in Europe? Dr Leonid…Dr Leonid Shapiro and Dr Joe Taylor in the new PharmaTimes article
11 December 2023Candesic Managing Partner Dr Leonid Shapiro and Principal Dr Joe Taylor discuss in an article in PharmaTimes Media Ltd how quantum computers can contribute to the development…Candesic Senior Partner Dr Michelle Tempest as a podcast guest
7 December 2023Candesic Senior Partner Dr Michelle Tempest joined Abdul Rahyead as a guest on a new episode of The Scrubbed In Show Podcast. The conversation centered on the transition…
